{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T00:42:27Z","timestamp":1758588147122,"version":"3.44.0"},"reference-count":19,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,12]],"date-time":"2025-03-12T00:00:00Z","timestamp":1741737600000},"content-version":"am","delay-in-days":376,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation Proceedings"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.transproceed.2023.12.012","type":"journal-article","created":{"date-parts":[[2024,2,6]],"date-time":"2024-02-06T01:13:38Z","timestamp":1707182018000},"page":"285-289","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Efficacy and Safety of Brachytherapy for Localized Prostate Cancer in Renal Transplant Recipients"],"prefix":"10.1016","volume":"56","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6963-5632","authenticated-orcid":false,"given":"Kensuke","family":"Mitsunari","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroki","family":"Kurata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Itsuho","family":"Ito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junki","family":"Harada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuichiro","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomohiro","family":"Matsuo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kojiro","family":"Ohba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasushi","family":"Mochizuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryoichi","family":"Imamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.transproceed.2023.12.012_bib0001","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1111\/j.1600-6143.2004.00450.x","article-title":"Cancer after kidney transplantation in the United States","volume":"4","author":"Kasiske","year":"2004","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2023.12.012_bib0002","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/ajt.14533","article-title":"Urologic malignancies in kidney transplantation","volume":"18","author":"Hickman","year":"2018","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2023.12.012_bib0003","first-page":"9","article-title":"Cancer statistics, 2014","volume":"64","author":"Siegel","year":"2014","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.transproceed.2023.12.012_bib0004","doi-asserted-by":"crossref","first-page":"33","DOI":"10.5114\/jcb.2013.34342","article-title":"Low-dose-rate or high-dose-rate brachytherapy in treatment of prostate cancer - between options","volume":"5","author":"Skowronek","year":"2013","journal-title":"J Contemp Brachytherapy"},{"key":"10.1016\/j.transproceed.2023.12.012_bib0005","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.ijrobp.2006.04.029","article-title":"Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: recommendations of the RTOG-ASTRO Phoenix Consensus Conference","volume":"65","author":"Roach","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.transproceed.2023.12.012_bib0006","doi-asserted-by":"crossref","first-page":"3416","DOI":"10.1093\/ndt\/gfq193","article-title":"Management of localized prostate cancer by retropubic radical prostatectomy in patients after renal transplantation","volume":"25","author":"Hoda","year":"2010","journal-title":"Nephrology Dial Transplant"},{"key":"10.1016\/j.transproceed.2023.12.012_bib0007","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.euf.2018.05.010","article-title":"Management of localised prostate cancer in kidney transplant patients: a systematic review from the EAU Guidelines on Renal Transplantation Panel","volume":"4","author":"Hevia","year":"2018","journal-title":"Eur Urol Focus"},{"key":"10.1016\/j.transproceed.2023.12.012_bib0008","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.rpor.2020.04.003","article-title":"Pelvic radiation therapy with volumetric modulated arc therapy and intensity-modulated radiotherapy after renal transplant: a report of 3 cases","volume":"25","author":"Ileana","year":"2020","journal-title":"Rep Pract Oncol Radiother"},{"key":"10.1016\/j.transproceed.2023.12.012_bib0009","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/nrurol.2017.76","article-title":"The evolution of brachytherapy for prostate cancer","volume":"14","author":"Zaorsky","year":"2017","journal-title":"Nat Rev Urol"},{"key":"10.1016\/j.transproceed.2023.12.012_bib0010","first-page":"975","article-title":"Gospodarowicz M; Genitourinary Cancer Disease Site Group of the Cancer Care Ontario Practice Guidelines Initiative. Systematic overview of the evidence for brachytherapy in clinically localized prostate cancer","volume":"164","author":"Crook","year":"2001","journal-title":"Can Med Assoc J"},{"key":"10.1016\/j.transproceed.2023.12.012_bib0011","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.brachy.2014.11.005","article-title":"Late rectal toxicity after low-dose-rate brachytherapy: incidence, predictors, and management of side effects","volume":"14","author":"Kishan","year":"2015","journal-title":"Brachytherapy"},{"key":"10.1016\/j.transproceed.2023.12.012_bib0012","doi-asserted-by":"crossref","first-page":"15","DOI":"10.5114\/jcb.2014.40769","article-title":"Iodine-125 prostate seed brachytherapy in renal transplant recipients: an analysis of oncological outcomes and toxicity profile","volume":"6","author":"Beydoun","year":"2014","journal-title":"J Contemp Brachytherapy"},{"key":"10.1016\/j.transproceed.2023.12.012_bib0013","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1111\/ctr.12773","article-title":"Prostate cancer characteristics and outcome in renal transplant recipients: results from a contemporary single center study","volume":"30","author":"Pettenati","year":"2016","journal-title":"Clin Transplant"},{"key":"10.1016\/j.transproceed.2023.12.012_bib0014","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1016\/j.transproceed.2016.01.031","article-title":"Efficacy and feasibility of low-dose rate brachytherapy for prostate cancer in ABO-incompatible renal transplant recipients","volume":"48","author":"Iizuka","year":"2016","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2023.12.012_bib0015","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/j.brachy.2018.06.001","article-title":"Low-dose-rate brachytherapy for prostate cancer in renal transplant recipients","volume":"17","author":"Rivero-Belench\u00f3n","year":"2018","journal-title":"Brachytherapy"},{"key":"10.1016\/j.transproceed.2023.12.012_bib0016","doi-asserted-by":"crossref","first-page":"155","DOI":"10.4149\/neo_2018_180507N298","article-title":"Radiotherapy of prostate cancer in renal transplant recipients: single-center experience","volume":"66","author":"Gojdic","year":"2019","journal-title":"Neoplasma"},{"key":"10.1016\/j.transproceed.2023.12.012_bib0017","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/j.transproceed.2018.10.027","article-title":"Low-dose-rate and high-dose-rate brachytherapy for localized prostate cancer in ABO-incompatible renal transplant recipients","volume":"51","author":"Tasaki","year":"2019","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2023.12.012_bib0018","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/980841","article-title":"HDR brachytherapy in the management of high-risk prostate cancer","volume":"2012","author":"Masson","year":"2012","journal-title":"Adv Urol"},{"key":"10.1016\/j.transproceed.2023.12.012_bib0019","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.brachy.2016.09.006","article-title":"American Brachytherapy Society Task Group Report: combination of brachytherapy and external beam radiation for high-risk prostate cancer","volume":"16","author":"Spratt","year":"2017","journal-title":"Brachytherapy"}],"container-title":["Transplantation Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134524000691?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134524000691?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T21:47:08Z","timestamp":1758577628000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041134524000691"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":19,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["S0041134524000691"],"URL":"https:\/\/doi.org\/10.1016\/j.transproceed.2023.12.012","relation":{},"ISSN":["0041-1345"],"issn-type":[{"type":"print","value":"0041-1345"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy and Safety of Brachytherapy for Localized Prostate Cancer in Renal Transplant Recipients","name":"articletitle","label":"Article Title"},{"value":"Transplantation Proceedings","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.transproceed.2023.12.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}